Dr. Rajeev Muni chats with Jay about the PIVOT trial examining pneumatic retinopexy versus vitrectomy for rhegmatogenous retinal detachment, and offers pearls on performing the procedure and managing patients after the procedure.
Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Alimera, Regeneron and Oxurion. Dr. Muni is a consultant/advisory board member for Novartis/Bayer/Allergan/Roche and receives research support from Novartis and Bayer.
CME Information
Release: Feb. 24, 2020; expires Feb. 24, 2023
Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.